A Repeated Time-to-Positive Symptoms Improvement among Malaysian Patients with Schizophrenia Spectrum Disorders Treated with Clozapine
Clozapine remains the drug of choice for resistant schizophrenia. However, its dose-response relationship is still controversial. The current investigation aimed to develop a repeated time-to-positive symptoms improvement following the onset of clozapine treatment in Malaysian schizophrenia spectrum...
Main Authors: | Orwa Albitar, Sabariah Noor Harun, Siti Nor Aizah Ahmad, Siti Maisharah Sheikh Ghadzi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/8/1121 |
Similar Items
-
Predictive model of recurrent ischemic stroke: model development from real-world data
by: Marwa Elsaeed Elhefnawy, et al.
Published: (2023-04-01) -
Efficacy of clozapine in patients with chronic schizophrenia
by: Varuni de Silva, et al.
Published: (2010-12-01) -
Cariprazine augmentation of clozapine in schizophrenia—a retrospective chart review
by: Marcin Siwek, et al.
Published: (2024-01-01) -
Efficacy of clozapine in patients with chronic schizophrenia
by: Varuni de Silva, et al.
Published: (2010-12-01) -
Treatment of bipolar mania with obsessive symptoms with clozapine: a case report
by: Shubhangi Parkar, et al.
Published: (2013-12-01)